PT - JOURNAL ARTICLE AU - Kahana, Michael J. AU - Wanda, Paul A. AU - Ezzyat, Youssef AU - Solomon, Ethan A. AU - Adamovich-Zeitlin, Richard AU - Lega, Bradley AU - Jobst, Barbara C. AU - Gross, Robert E. AU - Ding, Kan AU - Diaz-Arrastia, Ramon R. TI - Biomarker-guided neuromodulation aids memory in traumatic brain injury AID - 10.1101/2021.05.18.21256980 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.18.21256980 4099 - http://medrxiv.org/content/early/2021/05/22/2021.05.18.21256980.short 4100 - http://medrxiv.org/content/early/2021/05/22/2021.05.18.21256980.full AB - Traumatic brain injury (TBI) is a leading cause of cognitive disability in adults, often characterized by marked deficits in episodic memory and executive function. Prior studies have found that direct electrical stimulation of the temporal cortex yielded improved memory in epilepsy patients, but it is not clear if these results generalize to patients with a specific history of TBI. Here we asked whether applying closed-loop, direct electrical stimulation to lateral temporal cortex could reliably improve memory in a TBI cohort. Among a larger group of patients undergoing neurosurgical evaluation for refractory epilepsy, we recruited a subset patients with a history of moderate-to-severe TBI. By analyzing neural data from indwelling electrodes as patients studied and recalled lists of words, we trained personalized machine-learning classifiers to predict momentary fluctuations in mnemonic function in each patient. We subsequently used these classifiers to trigger high-frequency stimulation of the lateral temporal cortex (LTC) at moments when memory was predicted to fail. This strategy yielded a 19% boost in recall performance on stimulated as compared with non-stimulated lists (P = 0.012). These results provide a proof-of-concept for using closed-loop stimulation of the brain in treatment of TBI-related memory impairment.Competing Interest StatementB.C.J. receives research funding from NeuroPace, Inc. and Harvard Pilgrim, Inc. not relating to this research. R.E.G. serves as a consultant to Medtronic, which was previously a subcontractor on this project, and receives compensation for these services. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies. M.J.K. holds a greater than 5% equity interest in Nia Therapeutics Inc., a company intended to develop and commercialize brain stimulation therapies for memory restoration. R.E.G. holds a less than 5% equity interest in Nia Therapeutics, Inc. E.A.S. has served as a compensated technical consultant to Nia. P.A.W. is employed by Blackrock Microsystems Europe GmbH.Clinical TrialNCT04286776Funding StatementThe Defense Advanced Research Projects Agency provided funding for much of this work through Cooperative Agreement N66001-14-2-4032. The views, opinions, and/or findings contained in this material are those of the authors and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The enrolled patients participated at the following collaborating hospitals: Dartmouth-Hitchcock Medical Center (Hanover, NH), Emory University Hospital (Atlanta, Georgia), and University of Texas Southwestern Medical Center (Dallas, TX), with the University of Pennsylvania (Philadelphia, PA) serving as the Data Coordinating Center. This research was part of a multi-center project designed to assess the effects of electrical stimulation on memory-related brain function. Institutional review boards approved the study protocol at the respective institutions, and each participant gave written informed consent after the nature and possible consequences of the study were explained.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have posted all de-identified data, including EEG, localization information, and behavioral data, to the cognitive electrophysiology portal at memory.psych.upenn.edu. Correspondence and requests for materials should be addressed to M.J.K. http://memory.psych.upenn.edu/